
Everbright
Asia, Hong Kong Island, Hong Kong, Wan Chai'/%3e%3cuse xlink:href='%23a' transform='rotate(144 450 300)'/%3e%3cuse xlink:href='%23a' transform='rotate(216 450 300)'/%3e%3cuse xlink:href='%23a' transform='rotate(288 450 300)'/%3e%3c/svg%3e)
Description
Everbright is China’s cross-border investment and asset management company.
Investor Profile
Everbright has backed more than 11 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 9 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series A, Private Equity, Series C rounds (top funding stages).
- Majority of deals are located in China, United States, Hong Kong.
- Strong thematic focus on Health Care, Manufacturing, Biotechnology.
Stage Focus
- Series A (36%)
- Private Equity (18%)
- Series C (18%)
- Series D (9%)
- Series Unknown (9%)
- Series B (9%)
Country Focus
- China (73%)
- United States (18%)
- Hong Kong (9%)
Industry Focus
- Health Care
- Manufacturing
- Biotechnology
- Medical
- Logistics
- Real Estate
- Real Estate Investment
- Warehousing
- Fintech
- Internet
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
Who does Everbright frequently co-invest with?
What are some of recent deals done by Everbright?
Find More Investors Like Everbright
Discover similar investors in our database and build your perfect investor list.
Need help with your fundraising strategy?Read our fundraising guides








